Inceptor counteracts insulin signalling in β-cells to control glycaemia

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Ansarullah
  • Chirag Jain
  • Fataneh Fathi Far
  • Sarah Homberg
  • Katharina Wißmiller
  • Felizitas Gräfin von Hahn
  • Aurelia Raducanu
  • Silvia Schirge
  • Michael Sterr
  • Sara Bilekova
  • Johanna Siehler
  • Julius Wiener
  • Lena Oppenländer
  • Amir Morshedi
  • Aimée Bastidas-Ponce
  • Gustav Collden
  • Martin Irmler
  • Johannes Beckers
  • Annette Feuchtinger
  • Michal Grzybek
  • Christin Ahlbrecht
  • Regina Feederle
  • Oliver Plettenburg
  • Timo D. Müller
  • Matthias Meier
  • Matthias H. Tschöp
  • Ünal Coskun
  • Heiko Lickert

Research Organisations

External Research Organisations

  • Helmholtz Zentrum München - German Research Center for Environmental Health
  • German Center for Diabetes Research (DZD)
  • Technical University of Munich (TUM)
  • University of Freiburg
  • Technische Universität Dresden
View graph of relations

Details

Original languageEnglish
Pages (from-to)326-331
Number of pages6
JournalNATURE
Volume590
Early online date27 Jan 2021
Publication statusPublished - 11 Feb 2021

Abstract

Resistance to insulin and insulin-like growth factor 1 (IGF1) in pancreatic β-cells causes overt diabetes in mice; thus, therapies that sensitize β-cells to insulin may protect patients with diabetes against β-cell failure1–3. Here we identify an inhibitor of insulin receptor (INSR) and IGF1 receptor (IGF1R) signalling in mouse β-cells, which we name the insulin inhibitory receptor (inceptor; encoded by the gene Iir). Inceptor contains an extracellular cysteine-rich domain with similarities to INSR and IGF1R4, and a mannose 6-phosphate receptor domain that is also found in the IGF2 receptor (IGF2R)5. Knockout mice that lack inceptor (Iir−/−) exhibit signs of hyperinsulinaemia and hypoglycaemia, and die within a few hours of birth. Molecular and cellular analyses of embryonic and postnatal pancreases from Iir−/− mice showed an increase in the activation of INSR–IGF1R in Iir−/− pancreatic tissue, resulting in an increase in the proliferation and mass of β-cells. Similarly, inducible β-cell-specific Iir−/− knockout in adult mice and in ex vivo islets led to an increase in the activation of INSR–IGF1R and increased proliferation of β-cells, resulting in improved glucose tolerance in vivo. Mechanistically, inceptor interacts with INSR–IGF1R to facilitate clathrin-mediated endocytosis for receptor desensitization. Blocking this physical interaction using monoclonal antibodies against the extracellular domain of inceptor resulted in the retention of inceptor and INSR at the plasma membrane to sustain the activation of INSR–IGF1R in β-cells. Together, our findings show that inceptor shields insulin-producing β-cells from constitutive pathway activation, and identify inceptor as a potential molecular target for INSR–IGF1R sensitization and diabetes therapy.

ASJC Scopus subject areas

Sustainable Development Goals

Cite this

Inceptor counteracts insulin signalling in β-cells to control glycaemia. / Ansarullah; Jain, Chirag; Far, Fataneh Fathi et al.
In: NATURE, Vol. 590, 11.02.2021, p. 326-331.

Research output: Contribution to journalArticleResearchpeer review

Ansarullah, Jain, C, Far, FF, Homberg, S, Wißmiller, K, von Hahn, FG, Raducanu, A, Schirge, S, Sterr, M, Bilekova, S, Siehler, J, Wiener, J, Oppenländer, L, Morshedi, A, Bastidas-Ponce, A, Collden, G, Irmler, M, Beckers, J, Feuchtinger, A, Grzybek, M, Ahlbrecht, C, Feederle, R, Plettenburg, O, Müller, TD, Meier, M, Tschöp, MH, Coskun, Ü & Lickert, H 2021, 'Inceptor counteracts insulin signalling in β-cells to control glycaemia', NATURE, vol. 590, pp. 326-331. https://doi.org/10.1038/s41586-021-03225-8, https://doi.org/10.1038/s41586-021-03347-z
Ansarullah, Jain, C., Far, F. F., Homberg, S., Wißmiller, K., von Hahn, F. G., Raducanu, A., Schirge, S., Sterr, M., Bilekova, S., Siehler, J., Wiener, J., Oppenländer, L., Morshedi, A., Bastidas-Ponce, A., Collden, G., Irmler, M., Beckers, J., Feuchtinger, A., ... Lickert, H. (2021). Inceptor counteracts insulin signalling in β-cells to control glycaemia. NATURE, 590, 326-331. https://doi.org/10.1038/s41586-021-03225-8, https://doi.org/10.1038/s41586-021-03347-z
Ansarullah, Jain C, Far FF, Homberg S, Wißmiller K, von Hahn FG et al. Inceptor counteracts insulin signalling in β-cells to control glycaemia. NATURE. 2021 Feb 11;590:326-331. Epub 2021 Jan 27. doi: 10.1038/s41586-021-03225-8, 10.1038/s41586-021-03347-z
Ansarullah ; Jain, Chirag ; Far, Fataneh Fathi et al. / Inceptor counteracts insulin signalling in β-cells to control glycaemia. In: NATURE. 2021 ; Vol. 590. pp. 326-331.
Download
@article{1f5b1321aa68406fb66dd300ed0b98fa,
title = "Inceptor counteracts insulin signalling in β-cells to control glycaemia",
abstract = "Resistance to insulin and insulin-like growth factor 1 (IGF1) in pancreatic β-cells causes overt diabetes in mice; thus, therapies that sensitize β-cells to insulin may protect patients with diabetes against β-cell failure1–3. Here we identify an inhibitor of insulin receptor (INSR) and IGF1 receptor (IGF1R) signalling in mouse β-cells, which we name the insulin inhibitory receptor (inceptor; encoded by the gene Iir). Inceptor contains an extracellular cysteine-rich domain with similarities to INSR and IGF1R4, and a mannose 6-phosphate receptor domain that is also found in the IGF2 receptor (IGF2R)5. Knockout mice that lack inceptor (Iir−/−) exhibit signs of hyperinsulinaemia and hypoglycaemia, and die within a few hours of birth. Molecular and cellular analyses of embryonic and postnatal pancreases from Iir−/− mice showed an increase in the activation of INSR–IGF1R in Iir−/− pancreatic tissue, resulting in an increase in the proliferation and mass of β-cells. Similarly, inducible β-cell-specific Iir−/− knockout in adult mice and in ex vivo islets led to an increase in the activation of INSR–IGF1R and increased proliferation of β-cells, resulting in improved glucose tolerance in vivo. Mechanistically, inceptor interacts with INSR–IGF1R to facilitate clathrin-mediated endocytosis for receptor desensitization. Blocking this physical interaction using monoclonal antibodies against the extracellular domain of inceptor resulted in the retention of inceptor and INSR at the plasma membrane to sustain the activation of INSR–IGF1R in β-cells. Together, our findings show that inceptor shields insulin-producing β-cells from constitutive pathway activation, and identify inceptor as a potential molecular target for INSR–IGF1R sensitization and diabetes therapy.",
author = "Ansarullah and Chirag Jain and Far, {Fataneh Fathi} and Sarah Homberg and Katharina Wi{\ss}miller and {von Hahn}, {Felizitas Gr{\"a}fin} and Aurelia Raducanu and Silvia Schirge and Michael Sterr and Sara Bilekova and Johanna Siehler and Julius Wiener and Lena Oppenl{\"a}nder and Amir Morshedi and Aim{\'e}e Bastidas-Ponce and Gustav Collden and Martin Irmler and Johannes Beckers and Annette Feuchtinger and Michal Grzybek and Christin Ahlbrecht and Regina Feederle and Oliver Plettenburg and M{\"u}ller, {Timo D.} and Matthias Meier and Tsch{\"o}p, {Matthias H.} and {\"U}nal Coskun and Heiko Lickert",
year = "2021",
month = feb,
day = "11",
doi = "10.1038/s41586-021-03225-8",
language = "English",
volume = "590",
pages = "326--331",
journal = "NATURE",
issn = "0028-0836",
publisher = "Nature Publishing Group",

}

Download

TY - JOUR

T1 - Inceptor counteracts insulin signalling in β-cells to control glycaemia

AU - Ansarullah,

AU - Jain, Chirag

AU - Far, Fataneh Fathi

AU - Homberg, Sarah

AU - Wißmiller, Katharina

AU - von Hahn, Felizitas Gräfin

AU - Raducanu, Aurelia

AU - Schirge, Silvia

AU - Sterr, Michael

AU - Bilekova, Sara

AU - Siehler, Johanna

AU - Wiener, Julius

AU - Oppenländer, Lena

AU - Morshedi, Amir

AU - Bastidas-Ponce, Aimée

AU - Collden, Gustav

AU - Irmler, Martin

AU - Beckers, Johannes

AU - Feuchtinger, Annette

AU - Grzybek, Michal

AU - Ahlbrecht, Christin

AU - Feederle, Regina

AU - Plettenburg, Oliver

AU - Müller, Timo D.

AU - Meier, Matthias

AU - Tschöp, Matthias H.

AU - Coskun, Ünal

AU - Lickert, Heiko

PY - 2021/2/11

Y1 - 2021/2/11

N2 - Resistance to insulin and insulin-like growth factor 1 (IGF1) in pancreatic β-cells causes overt diabetes in mice; thus, therapies that sensitize β-cells to insulin may protect patients with diabetes against β-cell failure1–3. Here we identify an inhibitor of insulin receptor (INSR) and IGF1 receptor (IGF1R) signalling in mouse β-cells, which we name the insulin inhibitory receptor (inceptor; encoded by the gene Iir). Inceptor contains an extracellular cysteine-rich domain with similarities to INSR and IGF1R4, and a mannose 6-phosphate receptor domain that is also found in the IGF2 receptor (IGF2R)5. Knockout mice that lack inceptor (Iir−/−) exhibit signs of hyperinsulinaemia and hypoglycaemia, and die within a few hours of birth. Molecular and cellular analyses of embryonic and postnatal pancreases from Iir−/− mice showed an increase in the activation of INSR–IGF1R in Iir−/− pancreatic tissue, resulting in an increase in the proliferation and mass of β-cells. Similarly, inducible β-cell-specific Iir−/− knockout in adult mice and in ex vivo islets led to an increase in the activation of INSR–IGF1R and increased proliferation of β-cells, resulting in improved glucose tolerance in vivo. Mechanistically, inceptor interacts with INSR–IGF1R to facilitate clathrin-mediated endocytosis for receptor desensitization. Blocking this physical interaction using monoclonal antibodies against the extracellular domain of inceptor resulted in the retention of inceptor and INSR at the plasma membrane to sustain the activation of INSR–IGF1R in β-cells. Together, our findings show that inceptor shields insulin-producing β-cells from constitutive pathway activation, and identify inceptor as a potential molecular target for INSR–IGF1R sensitization and diabetes therapy.

AB - Resistance to insulin and insulin-like growth factor 1 (IGF1) in pancreatic β-cells causes overt diabetes in mice; thus, therapies that sensitize β-cells to insulin may protect patients with diabetes against β-cell failure1–3. Here we identify an inhibitor of insulin receptor (INSR) and IGF1 receptor (IGF1R) signalling in mouse β-cells, which we name the insulin inhibitory receptor (inceptor; encoded by the gene Iir). Inceptor contains an extracellular cysteine-rich domain with similarities to INSR and IGF1R4, and a mannose 6-phosphate receptor domain that is also found in the IGF2 receptor (IGF2R)5. Knockout mice that lack inceptor (Iir−/−) exhibit signs of hyperinsulinaemia and hypoglycaemia, and die within a few hours of birth. Molecular and cellular analyses of embryonic and postnatal pancreases from Iir−/− mice showed an increase in the activation of INSR–IGF1R in Iir−/− pancreatic tissue, resulting in an increase in the proliferation and mass of β-cells. Similarly, inducible β-cell-specific Iir−/− knockout in adult mice and in ex vivo islets led to an increase in the activation of INSR–IGF1R and increased proliferation of β-cells, resulting in improved glucose tolerance in vivo. Mechanistically, inceptor interacts with INSR–IGF1R to facilitate clathrin-mediated endocytosis for receptor desensitization. Blocking this physical interaction using monoclonal antibodies against the extracellular domain of inceptor resulted in the retention of inceptor and INSR at the plasma membrane to sustain the activation of INSR–IGF1R in β-cells. Together, our findings show that inceptor shields insulin-producing β-cells from constitutive pathway activation, and identify inceptor as a potential molecular target for INSR–IGF1R sensitization and diabetes therapy.

UR - http://www.scopus.com/inward/record.url?scp=85099954160&partnerID=8YFLogxK

U2 - 10.1038/s41586-021-03225-8

DO - 10.1038/s41586-021-03225-8

M3 - Article

C2 - 33505018

AN - SCOPUS:85099954160

VL - 590

SP - 326

EP - 331

JO - NATURE

JF - NATURE

SN - 0028-0836

ER -

By the same author(s)